The Journal of Pediatrics
Volume 155, Issue 5 , Pages 605-606 , November 2009

Cystic Fibrosis: Refining the Approach to Newborn Screening

  • Bridget Wilcken, MBChB, MD

      Affiliations

    • Corresponding Author InformationReprint requests: Bridget Wilcken, MBChB, MD, Children's Hospital at Westmead and University of Sydney, Locked Bag 4001, Westmead, New South Wales 2145, Australia.

References 

  1. Castellani C, Southern KW, Brownlee K, Dankert Roelse J, Duff A, Farrell M, et al. European best practice guidelines for cystic fibrosis neonatal screening. J Cyst Fibros. 2009;In press
  2. Sontag MK, Wright D, Beebe J, Accurso FJ, Sagel S. A new cystic fibrosis screening algorithm: IRT/IRT↑/DNA. J Pediatr. 2009;155:618–622
  3. Crossley JR, Elliott RB, Smith PA. Dried-blood spot screening for cystic fibrosis in the newborn. Lancet. 1979;1:472–474
  4. McKay KO. Cystic fibrosis: benefits and clinical outcome. J Inherit Metab Dis. 2007;30:544–555
  5. Southern KW, Mérelle MM, Dankert-Roelse JE, Nagelkerke AD. Newborn screening for cystic fibrosis. Cochrane Database Syst Rev. 2009;(1):CD001402
  6. Grosse SD, Boyle CA, Botkin JR, Comeau AM, Kharrazi M, Rosenfeld M, et al. Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs. MMWR Recomm Rep. 2004;53:1–36
  7. Wilcken B. Newborn screening for cystic fibrosis: techniques and strategies. J Inherit Metab Dis. 2007;30:537–543
  8. Rose SR, Brown RS, Foley T, Kaplowitz PB, Kaye CI, Sundararajan S, et al. Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics. 2006;117:2290–2303

PII: S0022-3476(09)00496-X

doi: 10.1016/j.jpeds.2009.05.015

The Journal of Pediatrics
Volume 155, Issue 5 , Pages 605-606 , November 2009

Article Tools